Ultra processed foods can increase the risk of obesity and diabetes, themselves risk factors for Alzheimer's disease.

However, relying on pharmaceutical drugs for weight loss, enhanced performance, or treatment of common ailments—without ...

The number of cases will increase, but the rates seem to be declining with every birth cohort that reaches advanced ages, ...

Eli Lilly launches Mounjaro in India, targeting the $150B weight-loss market. The GLP-1 drug offers diabetes control & major ...

What is obesity? Here's what you need to know about the disease expected to impact 50% of adults worldwide by 2050.

WalletHub released a new analysis ranking America's most overweight cities, based on obesity rates, health consequences and ...

Oklahoma City ranks 12th among the nation's most overweight cities, with one of the highest adult obesity rates, despite past ...

With the advent of GLP-1 drugs, perspectives about weight management are changing. Ted Kyle hopes the food industry can make some changes, too, to better serve all consumers.

MNC pharma major Eli Lilly has launched Mounjaro (tirzepatide), a weekly injection for obesity and type 2 diabetes, after obtaining approval from India’s Central Drugs Standard Control ...

The incidence and risk for suicidality and self-harm were low for individuals given glucagon-like peptide-1 receptor agonists for obesity and diabetes, according to results of a systematic review ...

AUGUSTA, Ga. — A new study says that one Georgia city is among the most overweight cities in the U.S. According to WalletHub, ...

According to a 2024 New York Times article, three-quarters of all adults in the United States are either overweight or obese. These rates are expected to continue to rise. And new data shows just ...